Beta-thromboglobulin (beta tg) and platelet factor 4 (PF4) in patients with myeloproliferative diseases.
Fabris
F
F
Luzzatto
G
G
Randi
M L
ML
Cella
G
G
D000925:Anticoagulants / Q000494:pharmacology; D016477:Artifacts; D001800:Blood Specimen Collection / Q000379:methods*; D002951:Citrates / Q000494:pharmacology; D019343:Citric Acid; D004730:Endothelium, Vascular / Q000378:metabolism; D006801:Humans; D015539:Platelet Activation; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology; D010978:Platelet Factor 4 / Q000032:analysis* / Q000378:metabolism; D013920:Thrombocythemia, Essential / Q000097:blood*; D014461:Ultracentrifugation / Q000379:methods; D001620:beta-Thromboglobulin / Q000032:analysis*
D000925:Anticoagulants; D002951:Citrates; D010975:Platelet Aggregation Inhibitors; D001620:beta-Thromboglobulin; D019343:Citric Acid; D010978:Platelet Factor 4